← brief for 2026-08-31 · Slowing decline

Sex in CKD trials: representation and treatment effects of cardiorenoprotective therapies.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

A review of 27 kidney trials found women made up less than half the participants, even though they have similar rates of disease. The study also showed that SGLT2 inhibitors and GLP-1 drugs helped men and women similarly, but because fewer women joined the trials, the benefit for women may be understated.

Who did this work

Bellos I · Athanasiou M · Nikita KS · Benetou V

Source

Article · PubMed, the drug frontier · 2026 Aug 31
https://pubmed.ncbi.nlm.nih.gov/42671242/